Monday - November 10, 2025
PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke
November 08, 2025
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release:

* * *

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke

*

Research Highlights:

* Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products